Notably, treatment of DLBCL cells with the E. coli L-asparaginase in the absence of glutamine led to a more pronounced DLBCL cell death compared to glutamine deprivation alone (Figure 2D), suggesting that L-asparaginase treatment targets additional metabolic pathways. Here, ASPG is linked to diffuse large B-cell lymphoma.